Q2 FY2026 · ended Jun 30, 2026 · Revenue $200.41M, -1.3% YoY · Filed Aug 5, 2026
GoodRx Holdings, Inc. (GDRX) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $200.4 million and net income of $8.5 million. Free cash flow was $80.5 million. As of Jun 30, 2026 it held $296.1 million in cash and investments and $539.0 million in total debt.
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- GDRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Santa Monica, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809519
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $200.4M | $194.0M | $194.8M | $196.0M | $203.1M |
| Operating income | $23.6M | $14.0M | $22.7M | $14.6M | $26.8M |
| Net income | $8.5M | $1.2M | $5.4M | $1.1M | $12.8M |
| Diluted EPS | $0.02 | $0.00 | $0.02 | $0.00 | $0.04 |
| Operating cash flow | $80.8M | $11.8M | $32.9M | $76.0M | $49.6M |
| Free cash flow | $80.5M | $10.7M | $31.6M | $74.3M | $49.2M |
| Total assets | $2.3B | $2.0B | $1.4B | $1.3B | $1.3B |
| Total liabilities | $1.7B | $1.4B | $787.8M | $724.8M | $675.7M |
| Stockholders' equity | $647.6M | $622.0M | $616.3M | $600.7M | $643.0M |
| Cash and investments | $296.1M | $235.7M | $261.8M | $273.5M | $281.3M |
| Total debt | $539.0M | $541.4M | $549.5M | $545.1M | $547.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Restatement
|
Nov 2, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 583 GoodRx Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.